The University of Florida
AGTC has extensive ties to The University of Florida’s Powell Gene Therapy Center and has multiple Sponsored Research Contracts at the University. These contracts cover basic research for many new product candidates as well as projects that will enhance the basic AAV technology platform.

Visit our sites now:

• Powell Gene Therapy Center
• University of Florida

Genzyme Corporation

In 2004 AGTC signed a collaboration agreement with Genzyme Corporation in Cambridge, MA to jointly develop novel gene therapies for patients with unmet medical needs. An additional goal of the collaboration is to work together to scale-up AGTC’s novel manufacturing technology to production volumes sufficient to support market launch of products to treat large patient populations.  The team recently completed pre-clinical proof of concept and safety studies for a treatment for Age-Related Macular Degeneration.

Visit us now: Genzyme Corporation